BrightGene Bio-medical TechnologyLt

BrightGene Bio-medical TechnologyLt is a company operating in the pharmaceutical industry.

BrightGene Bio-medical Technology Co Ltd is a research driven biopharmaceutical company that engages in the R&D and manufacturing of innovative medicine as well as special generic APIs and FDFs with primary strategic focus on the regulated market. We have an exciting and very promising innovative pipeline including immuno-oncological therapeutic agents, orally available GLP-1RA peptides for type 2 diabetes, antibody drug conjugates for solid tumor, novel non-antibody dependent tumor targeting conjugates for brain cancer and solid tumor brain-metastasis.

Company type

Products and services

Biopharmaceuticals, Finished Dosage Forms, APIs (Active Pharmaceutical Ingredients)

Markets

Oceania, North America (USA, Canada), Africa, Middle East Region (e.g. UAE), Central America (e.g. Mexico), East Asia (e.g. China, Japan, Korea), Europe – EU countries, Europe – non EU (e.g. UK, Russia, ex-CIS countries), South America (e.g. Brazil, Colombia), South Asia (e.g. India, Pakistan, Sri Lanka), South East Asia (e.g. Thailand, Philippines, Singapore)

Address

BrightGene Bio-medical TechnologyLt, Room C26-C27, Suzhou biological nano-technology park, Suzhou, China, 215123